5 Revealing Analyst Questions From Tenet Healthcare's Q1 Earnings Call
Is now the time to buy THC? Find out in our full research report (it's free).
Revenue: $5.22 billion vs analyst estimates of $5.15 billion (2.7% year-on-year decline, 1.3% beat)
Adjusted EPS: $4.36 vs analyst estimates of $3.13 (39.2% beat)
Adjusted EBITDA: $1.16 billion vs analyst estimates of $995.3 million (22.3% margin, 16.9% beat)
The company reconfirmed its revenue guidance for the full year of $20.8 billion at the midpoint
Management raised its full-year Adjusted EPS guidance to $12.56 at the midpoint, a 2.2% increase
EBITDA guidance for the full year is $4.08 billion at the midpoint, in line with analyst expectations
Operating Margin: 18.1%, down from 61.2% in the same quarter last year
Same-Store Sales rose 2.9% year on year (1.8% in the same quarter last year)
Market Capitalization: $15.61 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Stephen Baxter (Wells Fargo) asked about any nonrecurring items in Q1 and the drivers of higher revenue per case at USPI. CEO Saumya Sutaria cited improved contracting, higher acuity, and service mix changes, with no material one-time items beyond Medicaid supplementals.
Greg Hinenbach (Morgan Stanley Investment) questioned the M&A pipeline for ambulatory centers. Sutaria responded that the pipeline remains healthy and the company expects to meet or exceed its $250 million investment target, focusing on centers that support service diversification.
Joanna Gajuk (Bank of America) inquired about margin outperformance in the hospital segment. Sutaria and CFO Sun Park attributed it to expense discipline, operational efficiencies, and improved staffing, rather than any unusual items.
Ryan Langston (TD Cowen) asked about further potential for labor cost improvements. Sutaria explained the focus is now on retention and recruitment, stating contract labor is at a sustainable level, with future gains expected from building a stable workforce.
Ben Hendrix (RBC Capital Markets) sought clarity on the persistence of strong ambulatory rate growth. Sutaria indicated continued momentum is expected as the company shifts to higher-acuity procedures and leverages payer contracting advantages.
In coming quarters, our team will be watching (1) the pace of new ambulatory center openings and the impact of M&A activity on segment growth, (2) ongoing progress in labor recruitment and retention strategies as Tenet seeks to limit wage pressure and maintain care quality, and (3) any developments in federal healthcare policy or reimbursement models that could affect hospital and ASC operations. We will also monitor execution on capital deployment priorities, including share repurchases and debt management.
Tenet Healthcare currently trades at $168.01, up from $123.77 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it's free).
Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
The Ensign Group Earnings: What To Look For From ENSG
Healthcare services company The Ensign Group (NASDAQ:ENSG). will be reporting results this Thursday after the bell. Here's what investors should know. The Ensign Group met analysts' revenue expectations last quarter, reporting revenues of $1.17 billion, up 16.1% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts' sales volume estimates. Is The Ensign Group a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting The Ensign Group's revenue to grow 17.7% year on year to $1.22 billion, improving from the 12.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.55 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. The Ensign Group has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 0.6% on average. Looking at The Ensign Group's peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Tenet Healthcare delivered year-on-year revenue growth of 3.3%, beating analysts' expectations by 2.3%, and Quest reported revenues up 15.2%, topping estimates by 1.4%. Read our full analysis of Tenet Healthcare's results here and Quest's results here. Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices flat over the last month. The Ensign Group is down 8.7% during the same time and is heading into earnings with an average analyst price target of $166 (compared to the current share price of $138.93). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
San Francisco Chronicle
7 hours ago
- San Francisco Chronicle
Mayor Daniel Lurie's $15.9 billion budget approved amid criticism
After months of difficult negotiations at City Hall, the San Francisco Board of Supervisors on Tuesday gave final approval to Mayor Daniel Lurie's $15.9 billion budget, which closes an $800 million budget deficit by slashing spending. The board, which has a moderate majority since the last election, voted 10 to 1 to approve the budget, with Supervisor Jackie Fielder dissenting. Now the bill goes to Lurie's desk, and per law, he must sign it by Aug. 1. The journey to creating a two-year budget that addresses the city's structural deficit was turbulent, as Lurie faced opposition from unions and community groups that tried to block funding cuts. Ultimately, Lurie, who had campaigned on cutting wasteful spending, reduced funds to nonprofits and departments, made about 40 layoffs and eliminated over a thousand vacant positions. Supervisor Connie Chan, who is the board's budget chair, said she wouldn't celebrate the mayor's budget and warned that the future remains grim as San Francisco continues to deal with threats from the Trump administration of withholding federal funds. Lurie and the board agreed to start a $400 million reserve fund to deal with any potential loss of federal dollars, but even that could be insufficient as San Francisco gets billions from the federal government every year, including in the form of Medicaid reimbursements and FEMA disaster funds. Still, Chan acknowledged that the board 'came together despite our differences to meet this moment,' which she said was key to getting the budget deal done. Lurie's team declined to comment on Tuesday. Last week after the board passed the budget on first reading, the mayor called it the latest in 'a series of major legislative wins.' 'They voted unanimously to cut red tape for small businesses through our PermitSF legislation, and approved a real plan to support families living in RVs,' Lurie said. 'Thank you to the Board, and I look forward to building on what we've accomplished so far.' But not everyone is happy about the budget. Fielder took a page from former Supervisor Dean Preston and voted no on the budget because it included cuts to programs that serve the city's most vulnerable people. Preston, a fellow democratic socialist, voted no on every budget while he was supervisor because they included more money for the San Francisco police department. 'I cannot in good conscience vote in support of this budget,' Fielder said. 'I will be voting no with disappointment, with frustration but also with clarity about the kind of city we are fighting to become. We owe our residents more than austerity.' Throughout the budget negotiations, Fielder criticized the mayor's spending plan, including a last-minute compromise between Lurie and the board that stripped some of its ability to allocate specific funds to fight homelessness. As part of the budget deal, Lurie sought and received more power in determining how to spend revenue from Proposition C, a 2018 tax increase to fund homelessness initiatives. The board agreed to give up its power to oppose mayoral spending under $19 million with a supermajority vote. On the final day of voting, angry homelessness advocates, many from the Coalition on Homelessness, staged a silent protest. They wore black veils and paraded around City Hall with a casket labeled 'democracy.' The group also opposed a recent change to city policy that they say will put RV dwellers at risk of homelessness.
The Hill
10 hours ago
- The Hill
Memo advises GOP to extend ACA tax credits
President Trump's 'big, beautiful bill' pays for an extension of his 2017 tax cuts in part through slashing about $1 trillion from Medicaid over the next decade. Democrats across the country are ready to make these cuts the prominent issue ahead of the midterm elections. The memo notes that all benefits from those tax cuts will be nullified because of premium increases if the subsidies are not extended. PUP Research is the sister group to PUP Advocacy, a conservative advocacy organization. 'Unfortunately, data shows that the expiration of enhanced premium tax credits on January 1, 2026, will increase health care costs to a level that will counteract the tax benefits of OBBB for over 20 million people,' the group wrote. Extra subsidies that help people afford ObamaCare premiums that were put in place during the coronavirus pandemic are set to expire at the end of the year, and there are few signs Republicans are interested in tackling the issue at all. If Congress takes no action, premiums for subsidized enrollees are projected to increase by more than 75 percent starting in January 2026, according to health research group KFF. There is broad bipartisan and public support for extending the subsidies, and the memo cited recent polling from Trump pollster Fabrizio Ward that showed Republicans losing support in the most competitive districts if the tax credits expire. But if Republicans extend them, the poll showed they can gain an advantage against Democrats in the midterms. The Republican candidate that supports extending the tax credits would lead the Democrat on the generic ballot by 6 points overall.
